These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4542779)

  • 21. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adhesion of blood platelets to human arterial subendothelium: role of factor VIII-Von Willebrand factor.
    Bolhuis PA; Sakariassen KS; Sixma JJ
    Haemostasis; 1979; 8(3-5):312-23. PubMed ID: 315905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Von Willebrand factor and platelet adhesiveness.
    Meyer D; Larrieu MJ
    J Clin Pathol; 1970 Apr; 23(3):228-31. PubMed ID: 5310275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. II. Further purification with thiol-disulfide interchange chromatography and additional evidence for disulfide bonds susceptible to limited reduction.
    Harris RB; Johnson AJ; Hodgins LT
    Biochim Biophys Acta; 1981 May; 668(3):471-80. PubMed ID: 6786357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelets and von Willebrand disease.
    Ruggeri ZM; Zimmerman TS
    Semin Hematol; 1985 Jul; 22(3):203-18. PubMed ID: 3929388
    [No Abstract]   [Full Text] [Related]  

  • 29. The binding of bovine platelet aggregating factor to human platelets.
    Brown JE; Thuy LP
    Thromb Res; 1981 Apr 1-15; 22(1-2):41-51. PubMed ID: 7292446
    [No Abstract]   [Full Text] [Related]  

  • 30. Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities.
    Blatt PM; Brinkhous KM; Culp HR; Krauss JS; Roberts HR
    JAMA; 1976 Dec; 236(24):2770-2. PubMed ID: 1086910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood coagulation factor VIII (antihemophilic factor): with comments on von Willebrand's disease and Christmas disease.
    Barrow EM; Graham JB
    Physiol Rev; 1974 Jan; 54(1):23-74. PubMed ID: 4594032
    [No Abstract]   [Full Text] [Related]  

  • 32. Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor.
    Cooper HA; Bennett WP; White GC; Wagner RH
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1433-7. PubMed ID: 7041120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular structural studies of human factor VIII.
    McKee PA; Andersen JC; Switzer ME
    Ann N Y Acad Sci; 1975 Jan; 240():8-33. PubMed ID: 122889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the platelet function in von Willebrand-Juergen's syndrome--Discussion].
    Winckelmann G
    Hamatol Bluttransfus; 1969; 6():196-9. PubMed ID: 5306342
    [No Abstract]   [Full Text] [Related]  

  • 37. Factor VIII physiology and pathology in man.
    Koutts J; Howard MA; Firkin BG
    Prog Hematol; 1979; 11():115-45. PubMed ID: 392590
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pathophysiology of platelet anomalies and its analysis. (4). Abnormality of the platelet function in von Willebrand's disease].
    Yoshioka A; Takahashi Y
    Rinsho Byori; 1983 Nov; 31(11):1176-85. PubMed ID: 6423868
    [No Abstract]   [Full Text] [Related]  

  • 39. Separation of bovine Factor VIII-related antigen (platelet aggregating factor) from bovine antihemophilic factor.
    Brown JE; Baugh RF; Sargeant RB; Hougie C
    Proc Soc Exp Biol Med; 1974 Dec; 147(3):608-11. PubMed ID: 4475426
    [No Abstract]   [Full Text] [Related]  

  • 40. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.